Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus
Aim. To evaluate clinical efficiency of sulodexide (glycosoaminoglycan) for the treatment of patients with type 2 diabetes mellitus (DM2) and diabeticnephropathy (DN) at the stage of microalbuminuria (MAU). Materials and methods. A total of 30 patients with DM2 and MAU were examined 15 of whom wer...
Guardado en:
Autores principales: | Iya Vladimirovna Semenova, Lyudmila Alexandrovna Chugunova, Alexander Viktorovich Il'in, Anna Petrovna Knyazeva, Lidia Dmitrievna Chirkova, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e156276ee1b8436492a7037ca5257bbd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of microalbuminuria with ischemic heart disease in non-diabetic Asian-Indians: A case control study
por: Sowjanya Naha, et al.
Publicado: (2015) -
Effect of heparin on in vitro capacitation of boar sperm
por: DAPINO,DORA G, et al.
Publicado: (2006) -
Level of hydrogen sulfide in patients with type 2 diabetes mellitus depending on the presence of diabetic nephropathy
por: D.Yu. Kutsyk, et al.
Publicado: (2017) -
Aortic Stiffness Index And Carotid Intima-Media Thickness Are Independently Associated With The Presence Of Microalbuminuria In Patients With Type 2 Diabetes Mellitus
por: Turan Y, et al.
Publicado: (2019) -
Podocyte injury in diabetes mellitus
por: Irina Nikolaevna Bobkova, et al.
Publicado: (2014)